How One FDA Meeting Gave the MELAS Community a Voice

June 03, 2026 • 00:32:04
How One FDA Meeting Gave the MELAS Community a Voice
Energy in Action by MitoAction
How One FDA Meeting Gave the MELAS Community a Voice

Jun 03 2026 | 00:32:04

/

Show Notes

For families living with MELAS, the emotional toll of mitochondrial disease extends far beyond the diagnosis itself. In this episode of Energy in Action, Marcy Young is joined by PFDD panel participants Gordon, Jackie, and Cheryl to reflect on their experience speaking directly to the FDA about the realities of living with MELAS. Together, they share deeply personal stories about caregiving, advocacy, grief, progression, and the urgent need for better treatments and support for mitochondrial disease families.

The conversation explores what it was like to prepare for such a vulnerable and high-stakes meeting, how the panelists unexpectedly formed lasting bonds through the process, and why sharing the hardest parts of this disease matters. From navigating stroke-like episodes and delayed diagnoses to the emotional impact on siblings and caregivers, this episode offers an honest look at the ripple effects of MELAS — while also highlighting the hope that comes from advocacy, connection, and being heard.

In this episode, you’ll hear:

Resources & Ways to Connect

Learn More About MitoAction

Other Episodes

Episode

March 18, 2026 • 01:04:33
Episode Cover

How Mighty Matthew Keeps Moving Forward

Matthew Cech has spent his entire life adapting to mitochondrial disease, but his story is about far more than the medical challenges he has...

Listen

Episode 12

February 14, 2021 • 00:44:01
Episode Cover

Owning My Story...The DadVocate

Meet Rare Disease Dad, Adam Johnson!

Listen

Episode

January 21, 2026 • 00:29:48
Episode Cover

What PFDD Meetings Mean for the Mito Community

Patient-Focused Drug Development (PFDD) meetings are one of the most powerful advocacy tools available to rare disease communities—but most patients have never heard of...

Listen